Utility of Examining 100 Metaphase Cells in the Evaluation of Low‐Level Aneuploidy Mosaicism

Karyotype analysis is the gold standard of care for evaluating patients suspected of having mosaicism involving sex chromosomes or autosomes. Accurately determining the level of mosaicism is important, as it can vary widely and may be linked to disease severity. However, current guidelines do not clearly specify how many cells should be examined in order to exclude low-level mosaicism. In our retrospective study of cytogenetic results from 113 specimens, each with a minimum of 100 cells examined, we assessed whether the extensive analysis provided additional clinical value. Common indications for cytogenetic testing in these cases include Turner syndrome, premature ovarian failure, Klinefelter syndrome, infertility, and multiple miscarriages. In 83% (94/113) of cases, additional cells were examined because initial analysis suggested low-level mosaicism; however, further analysis did not confirm the initial findings in 66 of these 94 cases, indicating they were likely artifacts. Notably, none of the seven repeated analyses of 100 or 200 cells corroborated previous reports of low-level or clinically suspected mosaicism. Examination of additional cells confirmed the presence of a second cell line at low level in 25% (28/113) of cases, most often associated with X chromosome aneuploidies in adult females, likely age-related and without clear clinical significance. These results suggest that case-by-case consideration is still important, but no clinically significant findings resulted from analyzing more than 40 cells, indicating that extensive additional cell analysis is generally unnecessary for ruling out low-level mosaicism in clinical cytogenetic practice.

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part A
Published
2026-11-17
DOI
https://doi.org/10.1002/ajmg.a.70360
Primary Topic
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Utility of Examining 100 Metaphase Cells in the Evaluation of Low‐Level Aneuploidy Mosaicism

Aiko Iwata‐Otsubo, Pierce Cai, Lina Shao, Lynn Knudson-Horneber
1 links
American Journal of Medical Genetics Part A
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
article

Utility of Examining 100 Metaphase Cells in the Evaluation of Low‐Level Aneuploidy Mosaicism

Aiko Iwata‐Otsubo, Pierce Cai, Lina Shao, Lynn Knudson-Horneber
article en

Abstract

Karyotype analysis is the gold standard of care for evaluating patients suspected of having mosaicism involving sex chromosomes or autosomes. Accurately determining the level of mosaicism is important, as it can vary widely and may be linked to disease severity. However, current guidelines do not clearly specify how many cells should be examined in order to exclude low-level mosaicism. In our retrospective study of cytogenetic results from 113 specimens, each with a minimum of 100 cells examined, we assessed whether the extensive analysis provided additional clinical value. Common indications for cytogenetic testing in these cases include Turner syndrome, premature ovarian failure, Klinefelter syndrome, infertility, and multiple miscarriages. In 83% (94/113) of cases, additional cells were examined because initial analysis suggested low-level mosaicism; however, further analysis did not confirm the initial findings in 66 of these 94 cases, indicating they were likely artifacts. Notably, none of the seven repeated analyses of 100 or 200 cells corroborated previous reports of low-level or clinically suspected mosaicism. Examination of additional cells confirmed the presence of a second cell line at low level in 25% (28/113) of cases, most often associated with X chromosome aneuploidies in adult females, likely age-related and without clear clinical significance. These results suggest that case-by-case consideration is still important, but no clinically significant findings resulted from analyzing more than 40 cells, indicating that extensive additional cell analysis is generally unnecessary for ruling out low-level mosaicism in clinical cytogenetic practice.

American Journal of Medical Genetics Part A
University of Michigan (US)
Good health and well-being
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon